Delphi Private Advisors’s Celgene Corp CELG Stock Holding History

Delphi Private Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-84	Closed	-$10K	–	358
2016 Q4	$10K	Sell	84 -13	-13%	-$1.45K	0.02%	104
2016 Q3	$10K	Sell	97 -102	-51%	-$11K	0.02%	117
2016 Q2	$20K	Buy	199 +8	+4%	+$828	0.04%	92
2016 Q1	$19K	Sell	191 -11	-5%	-$1.13K	0.03%	101
2015 Q4	$24K	Buy	+202	New	+$23.4K	0.04%	93

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Delphi Private Advisors's CELG Position: Q1 2017 in Review

Delphi Private Advisors sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 84 shares — an estimated $10K sold.

Delphi Private Advisors first reported a position in CELG in Q4 2015 and held it in 5 quarters. The position peaked at $24K in Q4 2015. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Delphi Private Advisors reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Delphi Private Advisors sold 84 Celgene Corp shares in Q1 2017, an estimated $10K.
Delphi Private Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 5 quarters.
Delphi Private Advisors's Celgene Corp position peaked at $24K in Q4 2015.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Delphi Private Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.